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Enzyme activities of N.acetyl~l'-,cosamit'~yltrunsl'cras¢ (GIcNAc-Tas¢) t-V involved in N.linked compk~x.typ¢ ¢arboltydrate synthesis were deter. 
mined in a non.metastatic honnonc.depend~nt rut p¢o~tat~ umor (R332?.H) and a related, hormone-independent variant metastasizing tolymph 
nodes and lungs (R3327-MatL),Lu), tn the metastasi~in$ variant a significantly increased activity or both GIcNAc.Ta~ 11I and GIcNAc-'l'ase V 
was observed, wher~s the activities ofGleNAc-Ta~ [ and 11 w~re ssentially uncllanlied. The increase in activity of GIcNAc.Tas¢ Ill is particularly 
notcwortlw since it indicat~ that elevated expression of this enzyme cannot I:m considered its an exclusiv~ marker of hepatic maliilnaney, 
N-Acetyllllucosaminyltranffcras¢; Metasta,~is; Rat prostate tumor; R332?-MatLyLu 
1, INTRODUCTION 
Prostate cancer is one if the major lethal malignancies 
in males, and death is always caused by metastasis to 
lungs, skeleton or lymph nodes [1]. The R3327 prostate 
tumor in the Copenhagen rat is often used to investigate 
the process of prostate tumor cell metastasis. Several 
R3327 tumor variants have become available, with dif- 
ferences in hormone sensitivity, metastatic potential 
and target organ specificity [2]. We have used two of 
these variants, the R3227-H variant (hormone-sensitive 
and non-metastasizing) and the R3327-MatLyLu vari- 
ant (hormone-insensitive and metastasizing to lymph 
nodezi and lungs), to investigate he po~.~ibl¢ role of c¢11 
surface carbohydrates in the metastatic process. 
Malignant tranfformation of cells has often been 
found to be associated with an increa~ in the average 
molecular weight of N-linked complex-type c ll surface 
carbohydrates [3-10]. This increased molecular weight 
has been attributed to increased branching on the tri- 
mannosyl core caused by an elevated N-ac¢tylglu- 
cosaminyltransferase (GIcNAc-Ta~¢) V activity [11,12], 
to increased polyactosaminoglycan formation [8,10,I 3] 
or to increased ~ialylation [6,9], Furthermore, a correla- 
tion between (31cNAc-Tase V activity and metastatic 
behavior of cells was observed in marine MDAY-D2 
cells [14] and in oncogene-transfected rat 2 fibroblasts 
[15]. In NIH 3T3 cells expressing the N.ras proto-onco- 
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gen¢, an invasive potential was correlated with an in- 
creased GlcNAc-Tase III and V expression [10]. 
We have determined the activities of GIcNAc.Tase 
I-V, enzymes that are involved in the synthesis on N- 
linked complex-type di-, tri- and tetra-anti,unary gly- 
cans. in the R3327-H and the R3327-MatLyLu prostate 
tumor variants to investigate whether there is a correla- 
tion between altered 81ycosylation as indicated by 
changed glyco~yltransferas¢ levels and metastatic po- 
tential. We found that in the m¢tastasizin~ variant he 
activity of two of the branching OlcNAc-Tases was sig- 
nificantly increased. 
2. MATERIALS AND METHODS 
LI. Mtaerkd.¢ 
Oiillo~cchar[d¢ Man'. l~ 3(Man~tl~ 3(Man=l~ 6)M.ar ;~1 , 
6)Man/JI~4GIcNAc.81.~4GIcNAc(Man~GIcNAc:) was :' la:ed 
from the urine or loco-intoxicatcd sh~p [16]. which was kiu,~,;¢ sup- 
plied by Dr, C.D. Warren (Ma~tchusctts General Hospi- 
tal. Boston, MA). GlcNAcpi-.* 2Man¢l~ 3(Manal~ 6)Manp.O- 
(CH.,hCOOCH~ (GA-3139A) was a kind gift of Dr. O. HinsBaul 
(University of All~rta, Edmonton, Alia.). Oligosaccharides 
GIcNAc~I~2Man~I~3(GIcNAc~I-.,2Man,',I ~6)- Man,al~ 
4GIcNA¢ (d i). GIeNAcflI~ 2(GIeNAcffl.-, 4)Mortal 
3(GIcNA¢,~I ~ 2Murl¢l ~6)- Man,a I ~4GIeNA¢ (tri), GIeNAc/J I ..-+ 
2Man~tl-.+3(GlcNAcpl.~4) (GIeNA~I-~2Man¢I...*6)- Man/~'l...~ 
4GIcNAc (his) arld GIeNAepI-+ 2Man ~I...4 3(GIcNAc,~I-.+ 
2(GIcNAc/II ~6)Man al .-46)- Man~tt-~4GIcNA¢ (tri') w~re obtained 
by •-galactosidase (jack bean) digestion [17] of the corrcspondinl| 
ff4-t, alactosylated compounds, which were kindly donated by Dr. G. 
Strecker (Universit¢! de Lille, Villen,,uve d'Ascq. France). Amberlite 
1RA-743 wits obtained from Sillma (St, Louis, MO), 
UDP.[=~CIGIcNAc (302 Ci/mol) was obtained from Amersham in- 
ternatiomtl (Amer~ham, UK), and UDP-[~HJGIcNAc (18,S Ci/mol) 
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(tom Dapont.New EnMland Nuclear (Boston, MA), Unlabeled UDP- 
elk:NAt was purehasad from Sillma (St, Louis. MO). The unlabeled 
taEar nacl¢otide was used to dilute the radioactive compounds to the 
d=lired specific radioactivity. All other chemi~ls were of the ~t  
quality available from commercial r.ourc¢~, 
2,2. T.mors 
Col~nh~len r~t:. originally ohtained from the Mammalian Genet- 
i~ and Animal Production .~a:tion, National Caner Institute. Bc- 
thud.el, MD, were bred (brother x sister) and housed in our animal 
facilities according to the institutional animal w~farc regulations, The 
R3327.MatLyLu tumor (hormone.in=ndtiv¢ and metastmizin$ to 
lymph nod~ and lunMs) and R3327.H tumor (hormonc.f<nsltb~c and 
non.met~msLtin83 wcrc orisinally obtained from Drs, D.S, Coffey 
and J,T. hones (Johns Hopkins School of Medicine, Baltimo~, MD), 
They have b~n maintaingl by subcutaneous transplantation i  ~s- 
tratcd and intact male Coi~nhali~n rats, rcs~tively [Itll. Of each 
tP.mor variant, sp~.imens front thr~ different rats were analyzed, 
2.3. ~n=wlt¢ preJ~raliotu~ 
Tumors ..sere di~.~ct~ from the animah and cut into small pieces 
and homol~ni~d in 10 mM sodium eagodylate, pH 7,0. usinli a Poiy- 
Iron homollenia=r, The homo~,enatc contained 35-90 ms protein per 
ml and wa~ stotv, d at -20"C until use. Under this condition the enzyme 
preparations retained full activity for at least 6 months. The protein 
cono:ntration was determined a~ordinli to Peterson [19], 
2.4, Gtyem;yhra~er~¢ a.~xa,rs 
The meth0th for assaying the activity ofGIcNAc-Tas¢ I and II were 
modifigl from Harpaz und ~hachtcr [20], Incubation mixtures con- 
sisted or :50 nmot Man,GIcNA¢= (GIeNAc-Ta¢ l) or 100 nmol oliilo- 
taccharidc GA-3139A (GIcNAc-Ta= 1I), 70 nmol UDP.[~HIGIcNA¢ 
(s~.ilic ra:lloaetivity I Ci/mol), S/Jmol 2.(A'.morpholina|ethane- 
suil'onato (MEb~ buffer, pH 6,3, I/Jmnl MnCI=, 0,1 #1 Triton X-100 
and =11 homogematc (0,35-.O.9 ms of protein) in a total volume of S0 
/at, Incubations were conducted for 1-2 h at 37"C, In the case of 
GIeNA¢-Tas¢ 1 the reaction was stopped by the addition of 450#1 of 
H;O and the rr, ixtur¢ was parsed throuih a I ml column ofDowex [XtS 
000-200 m~h), Cl'.form, The elaam and 3 washes of0.$ ml of H:O 
each were collected and radioactivity incorporated into the ao:eptor 
oligor.l¢¢harid¢ was counted by liquid scintillation. In the atsay of 
GIcNA¢-Tuse II the r~aetion was stopped by the addition of $ml of 
H:O. Separation of the labelled olilio~h:tride product from the 
radioactive sull~r-Aonor substrat¢ was ¢~trricd out using Sop.PaR C. 1 
rever~.pha~ cart'id.qes (Water, Milford. MA) according to Pal¢ic et 
al. [~ i} ~hc activit;es of GIeNAc.TASE 111. IV and V were determined 
.min!.u1:~t,e~,.~y using oligosa=:haride di as a common a~:eptor sub. 
sir'ate. |neubations were cnnducted for 16 h at 37*C as deu:rihed by 
Koend¢l~an el al. [~7]. The reaction was stopped by adding 0.5 ml 
H:O and pasinil the mixture through a I ml column of Dowex I-Xg, 
Cl'.form, The column was washed twice with 0,? ml H=O. To the 
¢ombined eluates 150#1 2,7 M NaBHd0,1 M NaOH was added and 
the mixture was left at room temperature for I h, Excess of NaBH= 
was destroyed by the addition of 4 M acetic acid, Cations were re. 
moved by passing the mixture throul~h a column of 0.$ ml Dow~ 
:50W.XI6, H" form and borate was removed by passage over a 2 ml 
column of Amberllte IRA.743 column. The columns were washed 
~'ith 4,0 ml H;O. and the eluate was lyophiltzed and dissolved in 101:1 
/al H~O. Separation of the different products was ao:omplished by 
HPLC I17]. 
In all assays, control incubations were carried oat without a~:cptor 
to ¢orr=:t for endogenous ace=pier activity. A~ys  were done for each 
rat tumor homogenato at least in dupli~t=. In the HPLC assays 
radiola~led references were added to allow correct product identifies- 
lion, 
3. RESULTS AND DISCUSSION 
In this study we investigated the po~ible correlation 
between aberrant N-glycosylntion and tumorcell metas- 
tasis. The activity of GIoNA~,-Tase I-V was assayed in 
two rat prostate tumor variants, and for each enzyme 
the activity in the g3327-MatLyLa tumor relative to 
that in the R332?-H tumor was taken as a measure for 
the change in expression in the metastasizing cells. 
GlcNAc-Tas¢ 1 and II each catalyze a committed step 
in the synthesis of/V-linked complex.type di-antennary 
glycans [20], while the other enzymes arc involved in the 
formation of bisecte.d (GIcNAc-Tas¢ II!) [22] and tri- 
and tetra-antcnnary (GIcNAc-Tas¢ IV and V) [23,24] 
structures. The R332?-H tumor is hormone-dependent 
and grows well in intact animals bat not in castrated 
rats, while the hormone-independent g3327-MatLyLu 
tumor grows equally well in intact and castrated ani- 
mals [18]. Therefore the differences observed in the ac- 
tivities of the enzymes between the two variants arc 
most likely due to an acquired genetic disposition rather 
than to hormonal influences. 
No significant differcn~ I~twc=a the two variants 
was observed in the activity of GIcNAc-Ta~ I and 
GlcNAc-Tase iI (Table I). This indicates that th~ porch. 
tial to synthesize N-linked complex.type glycans is the 
same in both tumors. However, the activity of GlcNAc- 
Tasc III was highly increased in the metastasizing vari- 
ant, while the activity of GIcNAc-Ta'~¢ V was elevated 
to a lesser extent (Table 1, Fig. 1). GlcNAc-Tase IV 
activity was below detection in either variant, although 
we cannot rule out the possibility that some GIcNAc- 
Tas¢ IV activity is present in the H.variant (Fig. 1). 
An increased activity of GIcNAo-Ta.~ V has boon 
correlated with malignant transformation in several 
cases [10.-12.14,15], In a number of these ~ses cl0vation 
in the expression of this enzyme was associated with 
metastasis or invasiv¢ potential. 
Increased activity of GIcNAc-Tas¢ I11. on the other 
hand, has been suggested to be a marker specific of 
hepatic malignancy, as high activities of this enzyme 
have b~n reported in rat [17,253 and haman [26] 
Table i 
N-Acctylglucosaminyltransfera~ (GIeNAe.Tas¢) activiti~ 
(noel.rag "s protcin.h':) in the non.metastatic, hormone.dependent 
R332?-H and the metastatic, hormone-independent R332?.MatLyLu 
rat prostate tumor variants 
GIcNA- Linka~ formed Activity in Activity ratio 
Tas¢ (R3327- 
R~327.H R3327- MatLyLu 
MatLyLu R3327-H) 
I GIcNAcpl ~2Manofl-~3 4,7 5,0 1.1 
I1 GleN Ac/~ 1 --42 Man ocl-.46 10,8 14,2 1.3 
III GlcNAcfll--*#Man~l-*4 0,02 0,13 6,S 
1V GIcNAcfll-.~Man¢i ~3 <0.00.~ <0.005 
V GlcNAc~l~6Man,~l~6 0,O0.'i 0,013 2.6 
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Fig, I. Atgtl,, of GIcNAc-Ta~¢ Ill. 1V and V activid~ by HPLC. 
Transfera~ activi|ics were measured in homollcnatcs of the R332?.H 
(0) and the g332?-MatLyLu (S) prostate tame: variants usin~ olillo- 
sa~haride di as the accepter substrat¢. After incubation the products 
of illyeosyltransfera~ action were i~laled and reduced as de~ribed 
in z~lion 2. AnalDis of the r~altin~ materhtI was performed on a 
Liehrosorb-NH,. column. Elution was carried out ;u a flow rate of 2 
ml.min "~ usinl a linear Ivadient of acetonitrildlS rnM potatsium 
phosphate, pH $,2, startln| at 4:1 (v/v) and decreasing acetonitril¢ by 
0,2~&.min "~ [l?l. The arros~ indicate the elation positon of the reduced 
forms of (I) the substrate (di). and the products of (2) GIcNAc,Tas¢ 
IV (tri), (3) GlcNAc.Tas¢ Ill (bls) and (4) Gk:NAc.Ta~ V (tri'}, 
hepatomas, prcneoplastic hepatic nodules [27]. and in 
human liver cirrhosis (a condition that may result in the 
development of a primary hepatoma) [26], In rat 
he~tomas the increased GIcNAc-Tase lll activity was 
shown to correlate with the presence of bisected struc- 
tures on glycoproteins of hepatoma origin while these 
structures were absent on glycoproteins produced by 
normal liver [28,29]. Recently we have reported an in- 
creased activity of OlcNAc-Tase llI to occur in mouse 
NIH 3T3 fibroblasts ¢xpre~ing the human N.ras proto- 
oncogen¢ JIG], This result correlated well with lectin 
binding studies of surface glycopeptides of NIH 3T3 
cells transfected with eas-oncogenes, which showed an 
increased affinity for E-PHA [4], a lectin specific for 
bisected structures [30]. By analogy, based on the results 
obtained in the present study, we predict that an in- 
creased amount of bisected structures will also be pres- 
cnt on the R3327-MatLyLu cells, Elevated levels of 
GlcNAc-Tase Ill and bisected structures therefore are 
not an exclusive characteristic of neoplasia of Ihe liver, 
Moreover, it should be not~ that the presen~ of 
bisected structures at the cell surface or on circulating 
glycoproteins, as such is not necessarily indicative of a 
malignant status. Apart from the cases mentioned 
above, bisected structures hav¢ also been found on a 
number of normal glycoproteins, including ovalbumin 
[31]. ovotransf¢rrin [32], and ovomucoid [33] from hen 
oviduct: human red blood cell band 3 glycoprotein [34] 
and glycophorin [35]; and 7-glutamyllranspeptidase 
from bovine [36], rat [37] and human kidn¢y [38]. How- 
ever, although the presence of bisected structures is a 
normal characteristic of  some glycoproteins, an abet- 
rantiy increased expression of GlcNAc-Tase III and its 
products may well be correlated with malignant trans- 
formation and a metaslatic potential, 
Although recently some lectin-binding studies have 
been performed with R-3327 tumor variants none of 
them have provided information about the amount of  
bisected and tri'-antennary structures [39-.41]. How- 
cvcr, based on our results we expect an increased 
amount of  N-linked tri'-antennary structures to occur 
on the R3327.MatLyLu cells, in addition to the above 
mentioned increase in bisected structures, Since tumor 
cell adhesion is thought to play an important role in the 
establishment of site-specific tumor metastasis [42], and 
carbohydrate structures may act as specific ligands in 
cell-cell adhesion processes [43] it is tempting to specu- 
late about a role of the increased amount of bisected and 
tri'.al~tennary structures in the R3327-MatLyLu vari. 
ant in its metastasis to lymph nodes and lungs. 
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